Taysha Gene Therapies
TSHA
#7373
Rank
NZ$0.51 B
Marketcap
$2.51
Share price
5.63%
Change (1 day)
-2.09%
Change (1 year)

Operating Margin for Taysha Gene Therapies (TSHA)

Operating Margin as of November 2024 (TTM): -888.17%

According to Taysha Gene Therapies's latest financial reports and stock price the company's current Operating Margin is -888.17%. At the end of 2023 the company had an Operating Margin of -689.72%.

Operating Margin history for Taysha Gene Therapies from 2023 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-689.72%-89.36%
2022-6,483.45%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.